Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion type Assertion NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_head.
- NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion description "[Nuclear presence of survivin may be an independent biomarker for disease recurrence and overall survival in patients with Stage I and II melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_provenance.
- NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion evidence source_evidence_literature NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_provenance.
- NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion SIO_000772 17543072 NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_provenance.
- NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion wasDerivedFrom lhgdn-20090331 NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_provenance.
- NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_assertion wasGeneratedBy ECO_0000203 NP225803.RAc8D1XBlricvmc7SAwrzU_dIkNxtqP8l_3gVI4t8m9g8130_provenance.